ClinConnect ClinConnect Logo
Search / Trial NCT03416114

RegistRare: a Retro-prospective Registry of Rare Primary Headaches in Italian Tertiary Headache Centres

Launched by SILVIA BENEMEI · Jan 23, 2018

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Rare Headaches Epidemiology

ClinConnect Summary

The RegistRare trial is studying rare types of primary headaches, which are specific kinds of headaches that don’t occur because of another medical condition. This research is taking place in several specialized headache centers across Italy and is looking at how common these rare headaches are among patients over a three-year period. The study will collect information from patients who have already been diagnosed with these headaches (from May 2014 to April 2017) and will continue to gather new data each year after that.

If you or a loved one has been diagnosed with a rare primary headache and are interested in participating, you may be eligible to join this study. The main requirement is that you must have a confirmed diagnosis of one of these rare headaches and be willing to sign a consent form to participate. There are no specific exclusions, so almost anyone who meets the diagnosis criteria can join. Participants can expect to share their medical history and information about their headaches, which will help researchers better understand these conditions and improve care for others in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • diagnosis of rare primary headaches (Part One, Chapter 3 and Chapter 4, ICHD-3 beta)
  • signed informed consent
  • Exclusion Criteria:
  • none

About Silvia Benemei

Silvia Benemei is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative studies. With a focus on precision medicine and patient-centric approaches, the organization collaborates with leading healthcare institutions and researchers to develop and implement rigorous clinical trials. By prioritizing ethical practices and robust methodologies, Silvia Benemei aims to contribute valuable insights to the scientific community and facilitate the development of new therapies that address unmet medical needs. The sponsor is driven by a mission to enhance the quality of life for patients through evidence-based interventions and comprehensive care solutions.

Locations

Florence, , Italy

Patients applied

0 patients applied

Trial Officials

Silvia Benemei, MD

Study Chair

Careggi University Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials